A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients

Inclusion Criteria: * Male or female, ambulatory outpatients 18-79 years old at screening * Minimum 2-year history of Stage I/II hypertension * Qualifying blood pressure criteria for study entry and for randomization * Willing to adhere to the dietary compliance and undergo protocol procedures * Have a lifestyle that will permit him/her to attend all evaluations, including those conducted on consecutive days Exclusion Criteria: * Have any form of secondary hypertension * Have clinically significant respiratory or cardiovascular disease * Presence/history of coronary artery disease or peripheral vascular disease * Have diabetes mellitus, Type I or II * Have a history of hypersensitivity to nebivolol, metoprolol, or any beta-blocker